AR027394A1 - Uso de mirtazapina para el tratamiento de trastornos del sueno - Google Patents
Uso de mirtazapina para el tratamiento de trastornos del suenoInfo
- Publication number
- AR027394A1 AR027394A1 ARP010100585A ARP010100585A AR027394A1 AR 027394 A1 AR027394 A1 AR 027394A1 AR P010100585 A ARP010100585 A AR P010100585A AR P010100585 A ARP010100585 A AR P010100585A AR 027394 A1 AR027394 A1 AR 027394A1
- Authority
- AR
- Argentina
- Prior art keywords
- mirtazapine
- treatment
- disorders
- soil
- medicament
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Uso de mirtazapina para la preparacion de un medicamento para un nuevo método de tratamiento de un trastorno del sueno en un sujeto, cuyo tratamientocomprende la administracion de mirtazapina en una dosis unitaria de tratamiento que comprende entre 0 ,1 y 5 mg de mirtazapina, y un envase para el pacientepara el tratamiento de trastornos del sueno.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00200499 | 2000-02-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR027394A1 true AR027394A1 (es) | 2003-03-26 |
Family
ID=8171013
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP010100585A AR027394A1 (es) | 2000-02-11 | 2001-02-09 | Uso de mirtazapina para el tratamiento de trastornos del sueno |
Country Status (25)
Country | Link |
---|---|
US (1) | US6933293B2 (es) |
EP (4) | EP1658850A1 (es) |
JP (1) | JP5039994B2 (es) |
KR (1) | KR20020069371A (es) |
CN (2) | CN1395487A (es) |
AR (1) | AR027394A1 (es) |
AT (1) | ATE317261T1 (es) |
AU (1) | AU780439B2 (es) |
BR (1) | BR0108261A (es) |
CA (1) | CA2396209C (es) |
CO (1) | CO5271706A1 (es) |
CZ (1) | CZ302368B6 (es) |
DE (1) | DE60117122T2 (es) |
DK (1) | DK1257278T3 (es) |
ES (1) | ES2258071T3 (es) |
HK (1) | HK1049122B (es) |
HU (1) | HUP0204391A3 (es) |
IL (2) | IL150290A0 (es) |
NO (1) | NO328007B1 (es) |
PE (1) | PE20011080A1 (es) |
PL (1) | PL206073B1 (es) |
RU (1) | RU2270680C2 (es) |
SK (1) | SK287396B6 (es) |
WO (1) | WO2001058453A1 (es) |
ZA (1) | ZA200205238B (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040152055A1 (en) * | 2003-01-30 | 2004-08-05 | Gliessner Michael J.G. | Video based language learning system |
UA83666C2 (ru) | 2003-07-10 | 2008-08-11 | Н.В. Органон | Способ получения энантиомерно чистого миртазапина |
WO2005051349A2 (en) * | 2003-11-25 | 2005-06-09 | Aurobindo Pharma Ltd. | Pharmaceutical compositions of mirtazapine |
GB0417558D0 (en) * | 2004-08-06 | 2004-09-08 | Merck Sharp & Dohme | Novel combination therapy |
US20080112893A1 (en) * | 2004-10-14 | 2008-05-15 | Arai Jun-Ichiro | Atmosphere Modifying Method and Spray Agent and Spray Device Used in the Same |
JP2006137748A (ja) * | 2004-10-14 | 2006-06-01 | Daikin Ind Ltd | 雰囲気改変方法、並びに、それに用いられる噴霧剤及び噴霧装置 |
JP2007284363A (ja) * | 2006-04-13 | 2007-11-01 | Daikin Ind Ltd | 噴霧剤 |
EP2146993B1 (en) | 2007-04-11 | 2015-08-05 | Merck Sharp & Dohme B.V. | A method for the preparation of mirtazapine |
PT3261645T (pt) | 2015-02-27 | 2021-06-17 | Dechra Ltd | Estimulação do apetite, gestão da perda de peso, e tratamento da anorexia em cães e gatos |
CN111053735A (zh) * | 2020-02-25 | 2020-04-24 | 上海阶平医院管理有限公司 | 一种治疗失眠的冷敷凝胶 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL189199C (nl) | 1975-04-05 | 1993-02-01 | Akzo Nv | Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten. |
EP0813873B1 (en) | 1996-06-19 | 2002-02-13 | Akzo Nobel N.V. | Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitors |
WO1999025356A1 (en) * | 1997-11-14 | 1999-05-27 | Akzo Nobel N.V. | Use of mirtazapine for treating sleep apneas |
-
2001
- 2001-02-06 EP EP05109549A patent/EP1658850A1/en not_active Withdrawn
- 2001-02-06 AT AT01902410T patent/ATE317261T1/de active
- 2001-02-06 EP EP10178745A patent/EP2283840A1/en not_active Withdrawn
- 2001-02-06 WO PCT/EP2001/001221 patent/WO2001058453A1/en active IP Right Grant
- 2001-02-06 CZ CZ20022330A patent/CZ302368B6/cs not_active IP Right Cessation
- 2001-02-06 PL PL356721A patent/PL206073B1/pl not_active IP Right Cessation
- 2001-02-06 CN CN01803934A patent/CN1395487A/zh active Pending
- 2001-02-06 IL IL15029001A patent/IL150290A0/xx unknown
- 2001-02-06 DK DK01902410T patent/DK1257278T3/da active
- 2001-02-06 RU RU2002124141/15A patent/RU2270680C2/ru not_active IP Right Cessation
- 2001-02-06 EP EP05109547A patent/EP1656937A1/en not_active Ceased
- 2001-02-06 JP JP2001557563A patent/JP5039994B2/ja not_active Expired - Lifetime
- 2001-02-06 EP EP01902410A patent/EP1257278B1/en not_active Expired - Lifetime
- 2001-02-06 AU AU30247/01A patent/AU780439B2/en not_active Expired
- 2001-02-06 CN CNA2008100056868A patent/CN101229170A/zh active Pending
- 2001-02-06 BR BR0108261-2A patent/BR0108261A/pt not_active Application Discontinuation
- 2001-02-06 CA CA002396209A patent/CA2396209C/en not_active Expired - Lifetime
- 2001-02-06 ES ES01902410T patent/ES2258071T3/es not_active Expired - Lifetime
- 2001-02-06 HU HU0204391A patent/HUP0204391A3/hu unknown
- 2001-02-06 US US10/203,232 patent/US6933293B2/en not_active Expired - Lifetime
- 2001-02-06 KR KR1020027009536A patent/KR20020069371A/ko not_active Application Discontinuation
- 2001-02-06 SK SK1144-2002A patent/SK287396B6/sk not_active IP Right Cessation
- 2001-02-06 DE DE60117122T patent/DE60117122T2/de not_active Expired - Lifetime
- 2001-02-08 PE PE2001000141A patent/PE20011080A1/es not_active Application Discontinuation
- 2001-02-09 AR ARP010100585A patent/AR027394A1/es unknown
- 2001-02-09 CO CO01009904A patent/CO5271706A1/es not_active Application Discontinuation
-
2002
- 2002-06-18 IL IL150290A patent/IL150290A/en not_active IP Right Cessation
- 2002-06-28 ZA ZA200205238A patent/ZA200205238B/en unknown
- 2002-08-09 NO NO20023803A patent/NO328007B1/no not_active IP Right Cessation
-
2003
- 2003-02-24 HK HK03101379.6A patent/HK1049122B/zh not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2603086T3 (es) | Uso de la daptomicina | |
CO4290346A1 (es) | Formas de dosificacion de liberacion controlada de azitromicina | |
PT1173178E (pt) | Composicao compreendendo apomorfina e sildenafil e utilizacao da mesma para o tratamento da disfuncao erectil | |
AR026610A1 (es) | Un derivado pirrolidinacetamida solo o en combinacion para tratamiento de desordenes del sistema nervioso central | |
ES2164040T1 (es) | Uso de agonistas del sitio de union de la glicina o de inhibidores de la absorcion de la glicina para el tratamiento de trastornos neuropsiquiatricos. | |
AR037629A1 (es) | Formulaciones farmaceuticas que comprenden un derivado de platino | |
AR032132A1 (es) | Composicion farmaceutica que comprende una combinacion de un compuesto de tramadol y una droga anticonvulsiva y uso de la combinacion para preparar un medicamento | |
IL174562A0 (en) | Oros push-stick for controlled delivery of active agent | |
AR016798A1 (es) | Uso de una cepa de lactobacillus para la elaboracion de un medicamento | |
ES2167061T3 (es) | Formas de dosificacion para mejorar la disfuncion erectil en pacientes de sexo masculino. | |
BRPI0418213A (pt) | forma de dosagem, e, método para tratar dor em um paciente em necessidade do mesmo | |
UY27532A1 (es) | Forma de dosificación de liberación controlada dual. | |
UY25544A1 (es) | Forma de dosificación de nefazodona | |
CL2008003941A1 (es) | Uso de escitalopram o de una sal farmaceuticamente aceptable del mismo para preparar un medicamento util en el tratamiento del desorden compulsivo obsesivo. | |
NO20055531L (no) | Preparat for forbedret kognisjon og hukommelse | |
HK1045113A1 (zh) | 給予固定的曲馬朵和雙氯酚酸組合的口服給藥形式 | |
CO5200840A1 (es) | Combinacion de sustancias activas con clonidina | |
AR027394A1 (es) | Uso de mirtazapina para el tratamiento de trastornos del sueno | |
AR048318A1 (es) | Formulaciones de matriz orales que comprenden licarbazepina | |
BG104797A (en) | Use of dexmedetomi dine for sedative effect in patients in an intensive care unit | |
AR053780A1 (es) | Uso de mirtazapina s para la fabricacion de un medicamento para el tratamiento de los bochornos | |
DE60102590D1 (de) | Darreichungsformen zur behandlung von oralen mykosen | |
AR026254A1 (es) | El uso de una preparacion de liberacion controlada para la preparacion de un medicamento para aumentar la dosis o la exposicion sistemica de un farmaco queinhibe la fosfodiesterasa 4 | |
AR023687A1 (es) | Una composicion para el tratamiento de desordenes de la retina externa y el uso de un antagonista de glutamato para la manufactura de un medicamento parael tratamiento de desordenes de la retina externa | |
RU2002122084A (ru) | Комбинация лекарственных препаратов, включающая миртазапин, для лечения депрессии и связанных растройств |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |